Verdera is an exploration-stage uranium company focused on discovering and developing uranium deposits in New Mexico. The company’s primary asset is the Crownpoint and Hosta Butte Uranium Project, located in the Grants Uranium District. Verdera also holds several other uranium properties in the state, including Nose Rock and Ambrosia Lake. The company intends to use In-Situ Recovery (ISR) to extract uranium. This technique involves injecting a liquid solution into sandstone to dissolve uranium, which the company then pumps to the surface for processing into yellowcake. Verdera argues ISR requires lower capital costs than conventional mining and leaves a smaller surface footprint. As a pre-production business with no current revenue, Verdera focuses on exploration, resource definition, and permitting. If the company reaches production, Verdera plans to sell uranium directly to nuclear utilities through privately negotiated spot and long-term contracts. Strategic milestones include completing a preliminary feasibility study and obtaining licenses from federal and state agencies. enCore, a U.S. uranium producer, is a strategic shareholder. Verdera currently funds its operations through equity financing. The company faces risks including a lack of proven mineral reserves, potential permitting delays due to historical community opposition, and a significant royalty burden on future production.